AAKP’s role in Clinical Trials and Market Research
AAKP supports innovation in the kidney space. We are actively involved in market research – to share the patient voice and experience with renal companies and clinical trials – to create more and better treatment options for kidney patients, so they can achieve their aspirations.
You may have heard the term “clinical trials” but wonder what that means. Is a clinical trial something you can participate in? What do you need to do to get started? We have pulled together some information that you might find helpful as you decide whether you would like to participate in a clinical trial.
Clinical Trials and Market Research Opportunities
Below is a list of the Clinical Trials and Market Research opportunities that AAKP is partnering to raise awareness of. You can also use the search tool below to be matched to even more opportunities.
|ARENA 2 Study for primary dRTA||This clinical study is enrolling patients between 6 months and 65 years of age who have been diagnosed with distal renal tubular acidosis. The ARENA-2 trial is studying how well the medication ADV7103, taken twice a day, treats dRTA.||Click here to read more about this opportunity.|
|FALCON Study||FALCON is a Phase 3 clinical study evaluating the effectiveness and safety of bardoxolone methyl (an oral investigational drug) in patients with ADPKD. The investigational drug, study-related procedures, and doctor visits will be provided at no cost. Visit PKDstudy.com for more information.||Click here to read more about this opportunity.|
|Emerald Study||Ongoing Pediatric Clinical Trial. Parents – do you have a child between the ages of 2 and 12 with kidney disease who also struggles to manage high blood potassium levels?||Click here to read more about this opportunity.|
|Bristol-Myers Squibb Study||Do you struggle to manage FSGS or Minimal Change Disease? If so, you might be eligible to enroll in a new clinical trial. Visit www.KidneyClinicalTrial.com.||Click here to read more about this opportunity.|